[HTML][HTML] Intermittent androgen suppression for rising PSA level after radiotherapy

JM Crook, CJ O'Callaghan, G Duncan… - … England Journal of …, 2012 - Mass Medical Soc
Background Intermittent androgen deprivation for prostate-specific antigen (PSA) elevation
after radiotherapy may improve quality of life and delay hormone resistance. We assessed …

American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

BJ Davis, EM Horwitz, WR Lee, JM Crook, RG Stock… - Brachytherapy, 2012 - Elsevier
PURPOSE: To provide updated American Brachytherapy Society (ABS) guidelines for
transrectal ultrasound-guided transperineal interstitial permanent prostate brachytherapy (PPB). …

Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature

L Budäus, M Bolla, A Bossi, C Cozzarini, J Crook… - European urology, 2012 - Elsevier
CONTEXT: Prostate cancer (PCa) patients have many options within the realms of surgery or
radiation therapy (RT). Technical advancements in RT planning and delivery have yielded …

Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions

AV D'Amico, JW Denham, J Crook, MH Chen… - Journal of Clinical …, 2007 - ascopubs.org
Purpose We evaluated whether the timing of fatal myocardial infarction (MI) was influenced
by the administration of androgen suppression therapy (AST). Patients and Methods The …

[HTML][HTML] Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR …

…, M Gospodarowicz, JM Crook - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose Three small retrospective studies have suggested that patients undergoing
continuous androgen deprivation (CAD) have superior survival and time to progression if lower …

Landmarks in prostate cancer

NJ Sathianathen, BR Konety, J Crook, F Saad… - Nature Reviews …, 2018 - nature.com
The field of prostate cancer has been the subject of extensive research that has resulted in
important discoveries and shaped our appreciation of this disease and its management. …

Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma

…, A Bayley, R Bristow, P Chung, J Crook… - International Journal of …, 2007 - Elsevier
PURPOSE: To assess in a prospective trial the feasibility and late toxicity of hypofractionated
radiotherapy (RT) for prostate cancer. METHODS AND MATERIALS: Eligible patients had …

Intermediate-risk prostate cancer: stratification and management

F Preisser, MR Cooperberg, J Crook, F Feng… - European Urology …, 2020 - Elsevier
Context Intermediate-risk prostate cancer consists of a highly heterogeneous group of patients.
Owing to this heterogeneity and variable prognoses, it is challenging to provide uniform …

The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix

…, RG Pearcey, PK Joseph, L Portelance, J Crook… - Cancer, 1999 - Wiley Online Library
BACKGROUND It is unclear whether blood transfusion can overcome the negative impact
of anemia before or during radiotherapy (RT) in patients with carcinoma of the cervix. The …

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node …

…, C Holloway, K Mills, DW Petrik, JM Crook… - The Lancet, 2019 - thelancet.com
Background Whole breast irradiation delivered once per day over 3–5 weeks after breast
conserving surgery reduces local recurrence with good cosmetic results. Accelerated partial …